News & Events
OBI and ONDRI release large dementia dataset to accelerate brain research, discovery, and innovation
ONDRI in partnership with the Ontario Brain Institute (OBI) has released de-identified baseline data from the deeply phenotyped ONDRI Foundational Study (2013-2018).
This event is online and free of charge! Tuesday, January 11, 202212:00 pm - 1:00 pm EST To register click here.
Opportunities and Challenges from multiple Perspectives: *the Clinician, the Researcher, the Charity/Advocacy Organization* Free virtual public event Tuesday, June 22, 202110:00 – 11:00 AM EDT Dr. Sara Mitchell reviewed the literature and her personal experience with...
EVENT DETAILS Monday March 1, 2021 from 5:00 pm – 8:00 pm EST Dr. Black presented highlights from the Sunnybrook Dementia Study (1995 and still going strong!) Event was targeted to: Dr. Black’s colleagues & trainees (past and present) Patients & care partners...
Congratulations to ONDRI co-lead, Dr. Mario Masellis, for coordinating an international study that has been funded through JPND
Congratulations to ONDRI co-lead, Dr. Mario Masellis, for coordinating an international study that has received €1,086,421 in funding through the Joint Program in Neurodegenerative Disease (JPND) call entitled ‘Linking Pre-Diagnosis Disturbances of Physiological Systems to Neurodegenerative Diseases.’
Congratulations to Dr. Mario Masellis and all the contributors to this important report published by Alzheimer’s Disease International.
Queen’s University researcher and ONDRI co-lead Doug Munoz, PhD has been elected to the Canadian Academy of Health Sciences (CAHS) Fellowship, one of Canada’s premier academic honours.
ONDRI, Along With Other Expert Organizations, Weighs in on Aducanumab – an Alzheimer’s Disease Medication
A medication called aducanumab is in the early stages of review for potential approval in Canada. Aducanumab was recently approved, with conditions, in the U.S., where it can now be prescribed for mild Alzheimer’s disease. ONDRI joined with other expert organizations working in Alzheimer’s and dementia research to devise a consensus statement on Aducanumab.
The 2021 AAIC conference took place on July 26-30, 2021, in Denver, Colorado and concurrently as a virtual event. This annual conference is an opportunity to showcase important research in Alzheimer’s disease and dementia from around the world.
Dr. Richard Swartz, ONDRI co-lead, will be presenting his research on the complex impacts of COVID-19 on stroke risk, care and outcomes
ONDRI researchers have co-authored a paper highlighting promising new potential Parkinson’s Disease (PD) biomarkers (or early indicators of disease).
Neurodegenerative disease research innovations through ONDRI@Home, based in Waterloo, Ontario, were featured in a news release.
On March 9, 2021 Dementia Dialogue released the latest installment of its podcast entitled “Changing Roles in Dementia Research: From subjects to participants”. The episode features Jill Czuczman discussing her role as a care partner to her husband David, who is living with frontotemporal dementia, along with Dr. Rick Swartz, a stroke neurologist and ONDRI’s co-lead.
On behalf of the entire ONDRI team, we wanted to send out a hearty congratulations to Susan Bronskill, PhD. Dr. Bronskill who heads ONDRI’s Aim 4: Health Systems Research initiative, has been promoted to the rank of Professor at the Dalla Lana School of Public Health,...